Drug Therapy
- Medical management of benign prostatic hyperplasia
The goal is to maximize quality of life and minimize “bothersome” symptoms. Choices about medical therapy are guided by indication, effectiveness, side effects, as well as patient preference.
- Should my patients take their blood pressure medications in the evening to enhance cardiovascular benefit?
The focus should be to achieve blood pressure control and facilitate adherence, regardless of the timing of the medications.
- Born again: The many lives of metformin
Repurposing old drugs for new indications is not a new drug-development strategy.
- Should I consider metformin therapy for weight loss in patients with obesity but without diabetes?
The authors appraise the evidence to date for weight loss with metformin in this patient population.
- A practical guide for buprenorphine initiation in the primary care setting
The authors review changes in prescribing laws and outline buprenorphine induction protocols that can be adopted in the primary care setting.
- Heart failure with reduced ejection fraction: What’s new in the 2022 guideline?
Evidence-based and guideline-based medical therapies can help patients feel better, stay out of the hospital, live longer, and potentially improve left ventricular function.
- Resistant hypertension: A stepwise approach
The authors review the definition and prevalence of resistant hypertension and its diagnostic workup and management, including lifestyle modifications, drugs, and experimental therapies.
- Balancing the myths of corticosteroid therapy
No class of drug has more mythical attributes, interfaces with different medical specialties, or clinical street lore than corticosteroids.